Differential pharmacokinetics of acetohexamide in male Wistar-Imamichi and Sprague-Dawley rats: Role of microsomal carbonyl reductase

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 1, 2005, Pages 185-187

  Imamura, Yorishige ^a   Shimada, Hideaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Acetohexamide; Microsomal carbonyl reductase; Pharmacokinetics; Rat

Indexed keywords

ACETOHEXAMIDE; CARBONYL REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ALCOHOL DEHYDROGENASE; CARBONYL REDUCTASE (NADPH);

ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; LIVER MICROSOME; MALE; NONHUMAN; ORCHIECTOMY; PLASMA CLEARANCE; RAT; ANIMAL; BLOOD; COMPARATIVE STUDY; METABOLISM; MICROSOME; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; WISTAR RAT;

ACETOHEXAMIDE; ALCOHOL OXIDOREDUCTASES; ANIMALS; FEMALE; MALE; MICROSOMES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPECIES SPECIFICITY;

EID: 18444396252     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.185     Document Type: Article

References (20)

1. McMahon R. E., Marshall F. J., Culp H. W., J. Pharmacol. Exp. Ther., 149, 272-279 (1965).
2. Maser E., Biochem. Pharmacol., 49, 421-440 (1995).
3. Forrest G. L., Gonzalez B., Chem.-Biol. Interact., 129, 21-40 (2000).
4. Oppermann U. C. T., Maser E., Toxicology, 144, 71-81 (2000).
5. Imamura Y., Kojima Y., Otagiri M., J. Pharmacobio-Dyn., 10, 285-286 (1987).
6. Imamura Y., Iwamoto K., Yanachi Y., Higuchi T., Otagiri M., J. Pharmacol. Exp. Ther., 264, 166-171 (1993).
7. Imamura Y., Kimura R., Kozono Y., Otagiri M., Life Sci., 57, 1811-1817 (1995).
8. Imamura Y., Kozono Y., Mori Y., Takada H., Otagiri M., Biol. Pharm. Bull., 20, 924-926 (1997).
9. Girgis-Takla P., Chroneos I., Analyst (London), 104, 117-123 (1979).
10. Takagishi Y., Sato K., Tomita K., Sakamoto T., Yakugaku Zasshi, 99, 961-963 (1979).
11. Shimada H., Nagano M., Yasutake A., Imamura Y., J. Health Sci., 48, 201-202 (2002).
12. Tohei A., Mogi Y., Kon H., Hokao R., Shinoda M., Exp. Anim., 52, 437-439 (2003).
13. Shimada H., Takamure Y., Imamura Y., J. Health Sci., 49, 316-318 (2003).
14. Ryan D. E., Levin W., "Handbook of Experimental Pharmacology," Vol. 105, ed. by Schenkman J. B., Greim H., Springer-Verlag, Berlin, 1993, pp. 461-476.
15. Witkamp R. F., Nijmeijer S. M., Yun H., Noordhoek J., van Miert A. S., Drug Metab. Dispos., 21, 441-446 (1993).
16. Miyazawa M., Shindo M., Shimada T., Chem. Res. Toxicol., 15, 15-20 (2002).
17. Kato R., Kamataki T., Xenobiotica, 12, 787-800 (1982).
18. Waxman D. J., Dannan G. A., Guengerich F. P., Biochemistry, 24, 4409-4417 (1985).
19. Morgan E. T., MacGeoh C., Gustafsson J.-Å., Mol. Pharmacol., 27, 471-479 (1985).
20. Kato R., Yamazoe Y., "Handbook of Experimental Pharmacology," Vol. 105, ed. by Schenkman J. B., Greim H., Springer-Verlag, Berlin, 1993, pp. 447-459.